Dr Kavita Poply, MBBS, FRCA, FPM RCA, PhD

Reader
Centre: Cardiovascular Medicine and Devices
Email: k.poply@qmul.ac.uk
Profile
Dr Kavita Poply is a Reader at Queen Mary University of London and a Consultant in Pain Medicine and Neuromodulation at Barts Health NHS Trust, London. She is a highly accomplished and widely respected figure in the field of Pain Medicine, with a distinguished career dedicated to advancing clinical excellence, medical education, and translational research in pain management and neuromodulation. Her clinical practice is recognised for delivering compassionate, patient-centred care supported by the latest scientific evidence.
Dr Poply holds prestigious qualifications, including the Fellowship of the Royal College of Anaesthetists (FRCA) and the Fellowship of the Faculty of Pain Medicine (FFPMRCA). She earned her PhD from Queen Mary University of London for her groundbreaking research into brain responses to spinal cord stimulation using differential frequencies, demonstrating her strong commitment to academic rigour and innovation.
She is a pioneer in the field, having established the first-ever university-accredited programme in Neuromodulation. In addition to her clinical work, she is actively involved in pain research, including leading NIHR-funded clinical trials, and contributes extensively to academic and professional development in the field. She is supervising post doc student on the novel research in establishing
Dr Poply currently serves as:
- Programme Lead for the Postgraduate Certificate in Neuromodulation and Pain Management at Queen Mary University of London
- Co-Director of the Executive Education Programme in Neuromodulation (EEPIN) at City St Georges University of London
- Education Lead, Cardiovascular Medicine and Devices (CVMD), QMUL
- Deputy Director of the Pain Research Centre at St Bartholomew’s Hospital
- Examiner at the Royal College of Anaesthetists and the Faculty of Pain Medicine
- Board Member of the Neuromodulation Society of the UK and Ireland (NSUKI)
Her clinical expertise spans a broad spectrum of chronic and complex pain conditions, including:
- Spinal and musculoskeletal pain
- Neuropathic pain syndromes: CRPS, sciatica, brachialgia, post-surgical pain, shingles/pleuritic pain
- Chronic visceral and pelvic pain: abdominal, pelvic, groin (including post-surgical/neuropathic), vulvodynia, anal pain
- Headaches: migraine, cluster headache, facial pain, trigeminal neuralgia
Dr Poply is highly proficient in a wide range of interventional procedures and has spearheaded the implementation of advanced, evidence-based therapies through her leadership, teaching, and clinical expertise. These include:
- Anti-CGRP monoclonal antibody therapy for chronic migraine
- Spinal Cord Stimulation (SCS)
- Dorsal Root Ganglion (DRG) Stimulation
- Peripheral Nerve Stimulation (PNS)
- Occipital Nerve Stimulation for chronic migraine and cluster headache
Her specialised knowledge in neuromodulation allows her to offer minimally invasive and highly effective treatment options for patients with refractory and debilitating pain syndromes.
Dr Poply’s clinical practice is firmly grounded in evidence-based medicine, and she consistently receives outstanding patient feedback for her dedication and results.
Research
Group members
Dr Vivek Mehta, Anthony Mathur, Amrita Ahluwalia, Qasim Aziz
Summary
I am serving as a Deputy Director for Pain Research Centre at Barts Health NHS trust since 2020. Grants are as follows:
Clinical Outcomes in Neuromodulation - Medtronic
- Start Date: Aug 2024
- End Date: Aug 2026
- Principal Investigator: Kavita Poply, Vivek Mehta
- Value of Award: £365,747
- Value Attributable to Candidate: £57,000
Headache Community Service Development - Pfizer
- Start Date: Mar 2024
- End Date: Oct 2024
- Principal Investigator: Kavita Poply, Vivek Mehta
- Value of Award: £177,000
- Value Attributable to Candidate: 1.25 PA
EMEA PSR Inceptive - Medtronic (14BB66)
- Start Date: Oct 2024
- End Date: Oct 2026
- Principal Investigator: Kavita Poply, Vivek Mehta
- Value of Award: £178,000
- Value Attributable to Candidate: £723/pt
NIHR RADICAL Study - NIHR127457
- Start Date: Oct 2023
- End Date: Ongoing
- Principal Investigator: Kavita Poply
- Value Attributable to Candidate: £112/pt
Multifidus PET Study - Mainstay Medical (NCT04327817)
- Start Date: Feb 2022
- End Date: Feb 2025
- Principal Investigator: Kavita Poply, Vivek Mehta
- Value of Award: £297,015
- Value Attributable to Candidate: £157,752
PILOW Study - Boston Scientific (NCT03818074)
- Start Date: Mar 2021
- End Date: Mar 2024
- Principal Investigator: Kavita Poply, Vivek Mehta
- Value of Award: £182,938
- Value Attributable to Candidate: £132,900
DEFY-PET Study - Boston Scientific (NCT03716557)
- Start Date: Mar 2021
- End Date: Mar 2023
- Principal Investigator: Kavita Poply
- Value of Award: £167,000
- Value Attributable to Candidate: £35,000
RELIEF Global Outcome Study - Boston Scientific
- Start Date: Jul 2021
- End Date: Ongoing
- Principal Investigator: Kavita Poply
- Value of Award: £80,000
- Value Attributable to Candidate: £142/pt
Reactivate B Study - Mainstay Medical (NCT02577354)
- Start Date: Mar 2019
- End Date: Mar 2023
- Principal Investigator: Kavita Poply
- Value of Award: £409,000
- Value Attributable to Candidate: £167,890
Clinical Outcomes in Neuromodulation - Medtronic
- Start Date: May 2017
- End Date: May 2021
- Principal Investigator: Kavita Poply
- Value of Award: £250,000
- Value Attributable to Candidate: £250,000
Sponsors
- Barts Charity
- National Institute of Health and Research and Care Research (NIHR)
- The Spine Foundation
- Boston Scientific
- Abbotts
- Mainstay Medical
- Medtronic
- Saluda Medical
- Nevro
- Curonix
Collaborators
International Neuromodulation Society (INS)
https://aspnpain.com
Wisconsin Pain and Intervention Society (WISIPP)
https://wisipp2025.com
American Society of Pain and Neurosciences
https://aspnpain.com
Swiss Pain Institute
https://swisspain.ch
- Dr Simon Thompson, simon.thomson@nhs.net
- Professor Babita Ghai, PGI, India, ghaibabita1@gmail.com
- Dr Paresh Doshi, Mumbai, India, Dr._Paresh_Doshi@mail.vresp.com
- Dr Phillipe Rigoard, Poitiers, France, philipperigoard@yahoo.fr
- Professor Lawrence Poree, UCSF, California, Lawrence.poree@ucsf.edu
- Prof Alaa Abd-Elsayed, Wisconsin-Madison, US, abdelsayed@wisc.edu
- Professor Salim Hayek, Okohama, US salim.hayek@uhhospitals.org,
- Professor Ahmed Raslan, Oregon, raslana@ohsu.edu
- Sam Eldabe, Middlesbrough and Switzerland, seldabe@mac.com,
- James Fitzgerald, Oxford, James.Fitzgerald@ouh.nhs.uk,
- Stana Bojainic, Oxford, Stana.Bojanic@ouh.nhs.uk,
- Professor Chris Gilligan, Massachusetts, United States cgilligan@bwh.harward.edu
- Kiran Patel, New York, US, kiranpatelmd@yahoo.com
- Prof Frank Huygen, Netherlands, f.huygen@erasmusmc.nl
- Jan willem Kallewaard, Amsterdam, jkallewaard@rijnstate.nl
- Philippe Mavrocordatos, Switzerland, p.mavrocordatos@swisspain.ch
- Ashish Gulve, Middlesbrough, UK, ashishgulve@nhs.net
- Ganeshan Baranidharan, Leeds, UK, g.baranidharan@nhs.net
- Manohar Sharma, Liverpool, UK, manohar.sharma@nhs.net
- Amitabh Gulati, New York, US, amitabhgulati@gmail.com
- Anjum Bux, Kentucky, US, anjumbux1@gmail.com
- Mayank Gupta, Kansas City, US, mayank.g@kansaspainmanagement.com
- Manjit Matharu, London, manjit.matharu@nhs.net
- Alex Green, Oxford, alex.green@nds.ox.ac.uk
- Hemant Kalia, New York, US, drhemantkalia@gmail.com
- Kliment Gatzinsky, Gothemburg, kliment.gatzinsky@gu.se
- Lauren Peene, Belgium, laurens.peene@live.com
- Nivan Loganathan, Singapore, n.loganathan@smd23.qmul.ac.uk
- Dr Tim Deer, doctdeer@aol.com
- Dr Georgios Matis, gkmatis@yahoo.gr